ImmunoCellular Therapeutics, Ltd. Bonus & Incentive Agreements
8 Contracts & Agreements
- 2022 Equity Incentive Plan (Filed With SEC on December 20, 2022)
- Form of Change of Control Bonus Letter Agreement (Filed With SEC on August 13, 2018)
- IMMUNOCELLULAR THERAPEUTICS, LTD. STOCK OPTION GRANT NOTICE (2016 EQUITY INCENTIVE PLAN) (Filed With SEC on July 11, 2016)
- IMMUNOCELLULAR THERAPEUTICS, LTD. 2016 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: MARCH 11, 2016 APPROVED BY THE STOCKHOLDERS: JUNE 17, 2016 (Filed With SEC on July 11, 2016)
- ImmunoCellular Therapeutics, Ltd. Restricted Stock Unit Grant Notice (2006 Equity Incentive Plan) (Filed With SEC on August 7, 2015)
- IMMUNOCELLULAR THERAPEUTICS, LTD. STOCK OPTION GRANT NOTICE (2006 EQUITY INCENTIVE PLAN) (Filed With SEC on March 11, 2013)
- 2006 EQUITY INCENTIVE PLAN OF IMMUNOCELLULAR THERAPEUTICS, LTD. (As Amended and Restated as of October 24, 2011) (Filed With SEC on November 14, 2011)
- IMMUNOCELLULAR THERAPEUTICS, LTD. AMENDMENT NO. 4 TO 2006 EQUITY INCENTIVE PLAN (Filed With SEC on August 14, 2008)
